The aim of the protocol is to present an optimized procedure for the establishment of an in vitro blood-brain barrier (BBB) model based on primary porcine brain endothelial cells (pBECs). The model shows high reproducibility, high tightness, and is suitable for studies of transport and intracellular trafficking in drug discovery.
The aim of this protocol presents an optimized procedure for the purification and cultivation of pBECs and to establish in vitro blood-brain barrier (BBB) models based on pBECs in mono-culture (MC), MC with astrocyte-conditioned medium (ACM), and non-contact co-culture (NCC) with astrocytes of porcine or rat origin. pBECs were isolated and cultured from fragments of capillaries from the brain cortices of domestic pigs 5-6 months old. These fragments were purified by careful removal of meninges, isolation and homogenization of grey matter, filtration, enzymatic digestion, and centrifugation. To further eliminate contaminating cells, the capillary fragments were cultured with puromycin-containing medium. When 60-95% confluent, pBECs growing from the capillary fragments were passaged to permeable membrane filter inserts and established in the models. To increase barrier tightness and BBB characteristic phenotype of pBECs, the cells were treated with the following differentiation factors: membrane permeant 8-CPT-cAMP (here abbreviated cAMP), hydrocortisone, and a phosphodiesterase inhibitor, RO-20-1724 (RO). The procedure was carried out over a period of 9-11 days, and when establishing the NCC model, the astrocytes were cultured 2-8 weeks in advance. Adherence to the described procedures in the protocol has allowed the establishment of endothelial layers with highly restricted paracellular permeability, with the NCC model showing an average transendothelial electrical resistance (TEER) of 1249 ± 80 Ω cm2, and paracellular permeability (Papp) for Lucifer Yellow of 0.90 10-6 ± 0.13 10-6 cm sec-1 (mean ± SEM, n=55). Further evaluation of this pBEC phenotype showed good expression of the tight junctional proteins claudin 5, ZO-1, occludin and adherens junction protein p120 catenin. The model presented can be used for a range of studies of the BBB in health and disease and, with the highly restrictive paracellular permeability, this model is suitable for studies of transport and intracellular trafficking.
Cellular Structure and Function of the Blood-Brain Barrier
At the interface of the circulatory and central nervous system (CNS), the BBB acts as a key regulatory site for homoeostatic control of the CNS microenvironment, which is essential for proper function and protection of the nervous system. The site of the BBB is the endothelial cells lining the blood vessel lumen. In brain capillaries, endothelial cells form complex intercellular tight junctions and strongly polarized expression patterns of particular influx and efflux transporters ensure highly specific molecular transport between the blood and the brain 1. The structural components of the tight junction complexes include proteins from the occludin and claudin family, zonula occludens (ZO) proteins, cingulin, and associated junctional adhesion molecules (JAMs). Claudin 5 is particularly important in the paracellular junctional restriction. Induction and maintenance of this characteristic BBB endothelial phenotype involve dynamic interactions with surrounding cells, including pericytes, astrocytes, neurons and the basement membranes, which together with brain endothelial cells form the neurovascular unit (NVU)2,3. The mechanisms involved in these interactions are not yet fully understood, but include exchange of chemical signals between cells, which allows modulation of BBB permeability in the short term and induces long-term BBB features4. Astrocytes especially are known to contribute to the brain endothelial cell phenotype and are a source of regulatory factors such as glial-derived neurotrophic factor (affecting intracellular cAMP)5, basic fibroblast growth factor6, hydrocortisone7, and transforming growth factor β (TGF-β)8. The effect of TGF-β, however, has been debated9.
From In Vivo to In Vitro BBB
In vivo studies continue to provide valuable information on BBB biology. However, cell culture models can provide additional insights and constitute useful tools for understanding detailed molecular and functional aspects of the BBB in both health and disease. Although the complex interactions between the cell types and constituents of the BBB are difficult to fully achieve in in vitro models, there has been, since the first purification of brain endothelial cells and application of these in mono-cultures10,11,12, extensive development of the purification procedures and growth conditions of the BBB cell culture models, resulting in greater resemblance to the in vivo barrier. The commonly used in vitro BBB models are based on primary cells of rodent, porcine, and bovine origin, and on immortalized cell lines. Each model has different advantages and drawbacks. For comparison and model choice, validation markers such as expression of BBB enzymes, transporters, receptors, and structural proteins are used to create overviews of the current established models1.
Aim of the Protocol
One important feature of the BBB is barrier tightness and high TEER, yet a large number of the available models do not reflect well the in vivo levels. Incorporating development and optimization contributions from several laboratories, the aim of this protocol is to present a method for establishing a high TEER in vitro BBB model based on primary pBECs in MC with or without ACM, or in NCC with primary astrocytes of rat or porcine origin. The applied procedures and establishment of the model include efforts to eliminate contaminating cells and to improve differentiation of pBECs into a BBB phenotype. This work has resulted in the establishment of reliable, high TEER models with low paracellular permeability and good functional expression of key tight junctional proteins, transporters, and receptors. However, as the astrocytes are a contributing factor to the brain endothelial cell phenotype, the three different conditions of culture represent three different phenotypes of brain endothelial cells. The NCC model is specifically useful for studies of certain specialized mechanisms involved in drug discovery, transport studies and intracellular trafficking, as well as for investigation of cell-cell interactions where maximal expression of BBB features is advantageous.
Origin and History of the Protocol
The pBEC model described here is largely based on the porcine model developed at Eisai Laboratories (London) by Dr. Louise Morgan and colleagues, whichis based on a successful earlier bovine brain endothelial cell model13. The original method of cell preparation was a two-stage filtration using nylon meshes to catch the microvessels, followed by a subculturing step to improve purity. In the earlier development of the method, optimal BBB phenotype and barrier tightness were achieved by growth in supplemented medium, including ACM. Further modifications to the method were made by R. Skinner in Prof N. Rothwell's lab in Manchester UK14,15. The method was adopted by the Abbott laboratory, KCL London, where Patabendige made it significantly simpler to prepare by avoiding the use of astrocytes or ACM and by eliminating contaminating cells such as pericytes with puromycin. The first papers confirmed that the MC model preserved several important features of the in vivo BBB, including effective tight junctions, membrane transport systems and receptor-mediated transcytosis16,17,18,19,20. Later S. Yusof again tested astrocyte co-culture and found it significantly improved TEER, so this is the preferred variant currently used in the Abbott lab21. The model has now been successfully transferred to the M. Nielsen lab in Aarhus, where further modifications have been introduced (this protocol), including simplifying grey matter extraction, using only one mesh filtration step, and a single filter coating step combining collagen and fibronectin. The applied procedure for isolation of porcine astrocytes (this protocol) was based on protocols developed by the T. Moos laboratory in Aalborg, described by Thomsen et al22. The TEER and other properties of the model generated in London and Aarhus are similar, which lends confidence to the notion that the model is readily transferred between labs and responds well to careful observation and rationalization of method steps. Indeed, S. Yusof has now established the MC model in a tropical country (Malaysia)23, which involved further adjustment for local conditions and tissue sources.
Advantages over Alternative Methods and Currently Established Models
Compared to brain endothelial cells of bovine and rodent origin, pBECs provide the advantage of having a lower rate of loss of the in vivo BBB phenotype following isolation24. Furthermore, pBECs are capable of forming relatively tight endothelial barriers, even when grown in MC (800 Ω cm2)16 as compared to the commonly reported levels for monolayers of cell lines such as bEND.5 and bEND.3 (50 Ω cm2)25,26,27, cEND (300-800 Ω cm2)28,29,30, and cerebEND (500 Ω cm2)29,31,32, and primary brain endothelial cells of mouse (100-300 Ω cm2)33,34,35,36 and rat (100-300 Ω cm2)37,38. However, the TEER has shown dependency on the purification and culture procedures. In most cases, the addition of ACM or co-culture with astrocytes shows differentiating effects on the endothelial cells and an increase in tightness of the endothelial layers1. Nevertheless, with efforts to optimize the culturing conditions, only the bovine-based models have shown TEER values comparable to the porcine-based models (averages of 800 Ω cm2 in MC, up to 2500 Ω cm2 in astrocyte co-culture)13,39,40,41,42,43,44,45. As the models based on primary bovine brain endothelial cells have shown large variations, both between and within laboratories14,45,46,47,48, reproducibility could be an issue. In the pBEC model reported here, the contributing laboratories have achieved very similar TEER and paracellular permeability values with low variability, both in and between laboratories. Hence, it should be possible for other laboratories to establish a robust model with low variability using the method presented here. In addition to forming tight endothelial layers, models with pBECs have previously been validated by expression of tight junction proteins, functional BBB transporters, receptors and enzymes, and demonstrated suitability for a range of studies15,16,17,19,20,22,49,50,51,52,53,54,55,56,57,58,59. Furthermore, unpublished transcriptome data on the co-cultures of pBECs shows an expected profile of BBB transporters and receptors (unpublished results, Nielsen et al.).
The porcine-based BBB model has a further advantage as the genome, anatomy, physiology, and disease progression of the pig reflect the human biology to a higher degree than other established models60, which are favorable features for the pharmaceutical industry. As porcine brains are a common by-product of the meat industry, they constitute an easily accessible source of brain endothelial cells, minimizing the number of animals needed for the experiments, and providing a high purification yield from one porcine brain. Although purification and cultivation of primary cells is somewhat time-consuming and requires expertise for standardization in setting up the model, primary cells generate the most reliable BBB models. Immortalized cell lines cannot be a substitute, as important properties such as barrier tightness, transporter expression profiles, and microenvironment regulation do not reflect the experimental findings in vivo61,62. In vitro models provide the advantage of live-cell imaging with higher resolution, making visualization of intracellular processes possible by allowing a close proximity approach to the sampled or observed cells, using objectives with higher magnification and better optical quality63. This is not the case for the use of two-photon microscopy in living animals. Furthermore, in vitro models provide the ability to transfect cells, allowing visualization of tagged proteins and investigation of their trafficking.
Applications of the Model
The function of the BBB is not fixed and can be dynamically modulated in both physiology and pathology. In many neurological diseases, including neurodegenerative, inflammatory and infectious diseases, disruption and increased permeability of the BBB is observed64,65,66,67. In order to reduce and prevent disease progression and subsequent damage, identification and characterization of the molecular mechanisms underlying the modulation of the BBB are of major importance. In this context, reliable in vitro models are in high demand by the pharmaceutical industry, and furthermore play important roles in predicting BBB permeability of drugs to the CNS. Any in vitro model serving as a permeability screen should display a restrictive paracellular pathway, a physiologically realistic cell architecture and functional expression of transporter mechanisms68. Demonstrated in previous studies16,17,57, and by paracellular permeability and expression of TJ and AJ proteins here, the presented model meets all these criteria and is suitable for a range of BBB studies in both normal physiology and in pathology. The strengths of the presented purification and cultivation method include a combination of simplicity and reproducibility and the ability to include astrocytic influence with a resulting robust and reliable high TEER in vitro BBB model. For this purpose, astrocytes of porcine and rat origin have been shown to augment the BBB phenotype of pBECs in a similar way22.
Porcine brains were obtained as byproducts of the Danish food industry. Danish Slaughterhouses are under strict supervision and observation by the Danish Ministry of Environment and Food.
Rats used for isolation of astrocytes were bred and group-housed in the local animal facility at an ambient temperature of 22 °C-23 °C and on a 12/12 h dark/light cycle under inspection of the veterinarian and according to Danish regulations for lab animals. The rats were euthanized before they were sacrificed in accordance with international guidelines on the ethical use of animals (European Communities Council Directive of 24 November 1986; 86/609/EEC) and Danish guidelines. No in vivo experiments on animals or human material were used in these experiments.
NOTE: Following is a pBEC main protocol describing (Step 1) purification, (Step 2) cultivation and (Step 3) TEER measurements. For setup of a NCC with astrocytes, an alternate protcol (Step 4) describing purification and cultivation of rat and porcine astrocytes is presented.
1. Purification of Porcine Brain Capillaries
2. Cultivation of Primary pBECs (8-10 days)
3. TEER Measurements
4. PREPARATION OF ASTROCYTES FOR NON-CONTACT CO-CULTURE: Alternative Method
Establishment of the BBB In Vitro Models
In the presented, optimized method, cultivation of pBECs and the establishment of the permeable membrane insert system with MC or without ACM or NCC with astrocytes (Figure 1) was carried out for a period of 9-11 days (Figure 2). For selection of endothelial cells, an initial culture of purified capillary fragments was combined with puromycin treatment for a maximum of 5 days, which eliminated most contaminating cells and promoted the growth of spindle-shaped endothelial cells from the capillary fragments (Figure 3A-C). At day 4-6, pBECs had proliferated to a confluency of 60-95%, growing as non-overlapping, contact-inhibited, longitudinally aligned cells. When the cells had reached the desired confluency, pBECs were plated on collagen IV and fibronectin coated permeable membrane insert filter membranes (1.12 cm2 surface area, 0.4 µm pores) at a density of 1.1 x 105 cells/insert, at which they normally formed confluent monolayers after 4 days (day 8-10 post isolation). When co-culturing pBECs, astrocytes of rat or porcine origin were plated on poly-L-lysine coated bottom wells for a minimum of 2 weeks before starting the NCC (Figure 3D). When establishing the NCC, experience has shown that astrocytes cultured for 2-8 weeks provide the best support for promoting the BBB phenotype in pBECs; within this time, the astrocytes formed confluent cultures with cells arranged in a honeycomb-like structure (Figure 3E-F). On day 4 in the permeable membrane insert system model (day 8-10 post isolation), cells were stimulated with cAMP, hydrocortisone and RO to increase the barrier tightness and BBB characteristic expression pattern of tight junctional proteins, transporters, and receptors.
Characterization of pBEC Phenotype and Paracellular Permeability
Visual cell inspection combined with TEER measurement are routinely the most reliable ways to assess the confluency and tightness of the endothelial cell layer growing on the permeable membrane inserts prior to experiments. Figure 4 shows results from two series of experiments to assess small molecule drug permeability through the BBB, the control parameters of TEER (reflecting ionic permeability) combined with apparent permeability21 (Papp, cm s-1) of either radiolabeled sucrose or the dye tracer Lucifer yellow (LY), reflecting paracellular permeability of typical small drug molecules (~200-600 Da). A compound of interest with a Papp greater than the Papp of sucrose or LY (depending on the molecular weight of the drug) could suggest transcellular permeability and/or transport across the cells. Figure 4 shows that in permeable membrane inserts with pBECs cultured above rat astrocytes, good batches of pBEC (e.g. here the LY set) will generate TEERs in the range ~500-2000 Ω cm2, with a few higher or lower. Some batches, especially during early stages of learning the protocol, may have lower TEERs around 100-900 Ω cm2 (e.g. here the sucrose set). TEER measurement allows selection of filters, for example with starting TEER >500 Ω cm2, and over the range of TEER shown, Papp is relatively independent of TEER, indicative of a sufficiently tight barrier layer for these experiments. The protocol for measuring permeability depends on the type of solute/construct. For a description of the procedure for measuring permeability of small molecules in NCC, a protocol is described in Yusof, SR, et. al21. Evaluation of expression of the tight junction proteins in pBECs in NCC with rat astrocytes showed localization of claudin 5, occludin, and ZO-1 along the cell-cell junctions, as shown by immunofluorescence (Figure 5A-C). Also, the adherens junction protein p120 catenin showed well-defined distribution along the cell-cell junctions (Figure 5D).
Figure 1: Schematic representation of the applied in vitro BBB models. Schematic representation of the permeable membrane insert system models of pBECs in MC (A), MC with ACM (B), and NCC with astrocytes (C). In the MC, either pBEC growth medium or ACM were applied in the bottom wells, whereas in the NCC, inserts with pBECs were placed in wells with 2-8-week-old astrocytes. Please click here to view a larger version of this figure.
Figure 2: Flow chart of the main steps during pBEC cultivation and the establishment of the presented models. For an overview and timeline for the method, this schematic presentation summarizes the main steps in the culturing procedure of pBECs and establishment of the presented models, i.e. MC with or without ACM, and NCC with astrocytes. Please click here to view a larger version of this figure.
Figure 3: Representative time course of initial cultures of pBECs and rat astrocytes. Phase contrast microscopy images of cultures of pBECs (A-C) and astrocytes (D-F) viewed over 5 days. Purified capillary fragments on the first day of the initial culture showed presence of both capillaries and contaminating cells (A, day 1), which after medium change on day 2 and an additional day of growth, showed selection for pBECs, starting their growth from the capillary fragments (B, day 3). Confluent monolayers of pBECs were usually achieved on day 4-6, at which time pBECs showed spindle-shaped morphology and were longitudinally aligned (C). Rat astrocytes seeded in bottom wells normally proliferated to confluent layers within 5 days (D-F), and were used for NCC models after 2 weeks of growth. Scale bar for all pictures: 200 µm. Please click here to view a larger version of this figure.
Figure 4: Tight junction integrity of pBECs. Apparent permeability (Papp) of pBECs to paracellular markers Sucrose (MW 342.5 14C-labelled, 14.8-25.9 GBq/mmol) and Lucifer Yellow (MW 521.57, 10 µg mL-1), plotted against TEER. pBECs were grown on 1.12 cm2 permeable membrane insert filters above rat astrocytes in the base of the well and markers added to the apical chamber. After 1 hour at 37 ˚C, appearance of marker in the basal chamber was measured and apical-to-basal Papp (x 10-6 cm sec-1) calculated. TEER was measured >3 h before Papp, using STX100C EVOM electrodes, corrected for the blank permeable membrane insert filter with resistance 150 Ω. Average TEER for the Lucifer Yellow data set was 1249 ± 80 Ω cm2 (mean ± SEM, n=55). Please click here to view a larger version of this figure.
Figure 5: Immunocytochemical characterization of pBECs. For pBECs grown on 1.12 cm2 permeable membrane insert filter inserts above rat astrocytes in the base well, immunofluorescence microscopy analysis of the tight junction components (A) Claudin 5 (B) Occludin (C) ZO-1, and adherens junction protein (D) p120 catenin showed well-defined localization at cell-cell junctions and revealed confluent brain endothelial cell layers with spindle-shaped, non-overlapping cells. Scale bar for all pictures: 10 µm. Please click here to view a larger version of this figure.
Purification and Proliferation of pBEC
During the purification procedure, critical steps include rapid and effective removal of meninges and separation of white and grey matter, which is important for the purification yield and purity and for the proper establishment of the model. For the presented in vitro BBB model using pBECs, we have improved and simplified a purification procedure based on mechanical homogenization of isolated grey matter, size-selective filtering for isolation of microvessels, digestion with collagenase, DNase and trypsin, with an initial culture of microvessel fragments. In general, one of the major challenges during purification and cultivation of primary cells is the elimination of contaminating cells. Experience with purification of primary brain endothelial cells has indicated that thorough removal of both meninges and white matter results in improved purity and yield of capillaries, as well as increased endothelial cell growth and expression of BBB characteristics. For this reason, careful removal of meninges (including inside sulci) in the presented protocol was designed to ensure removal of leptomeningeal cells (which have fibroblast-like properties), as well as of arterial and arteriolar smooth muscle cells, which grow more rapidly than endothelial cells in culture. Likewise, minimization of the white matter material resulted in purer endothelial cell cultures, with fewer contaminating cells growing from the isolated capillary fragments. However, this simplified and quick method applied for isolation lowers the yield of isolated capillaries, and optimization of grey matter isolation could improve the yield of each brain significantly. A density gradient, which is included in an alternative purification protocol69, can be used for isolating free endothelial cells and improving endothelial cell purity, but it is time consuming and can likewise lower the yield. Both of these purification methods have been extensively used and characterized, and share the characteristics of generating high TEER pBEC models in both MC and astrocyte co-culture (normally 500-1500 Ω cm2)7,16,21,22,49,57,70,71.
In order to establish monolayers with high paracellular restrictiveness, experience has shown that pericytes must be eliminated from the endothelial cultures16. Porcine brain pericytes generally grow below the pBEC layers and do not cause holes in the endothelial layers, as observed for cultures of rat brain endothelial cells72,73. Pericytes in pBEC cultures do, however, tend to affect the morphology of the endothelial cells, which appear broader and with irregular cell boarders16. Because brain endothelial cells express higher levels of efflux transporters (e.g. P-glycoprotein) than other cell types in the microvessels, the number of contaminating cells can be reduced by puromycin treatment74. Additionally, use of plasma-derived serum (PDS) rather than fetal or neonatal calf derived serum favors the growth of endothelial cells, as the PDS has a lower concentration of growth factors such as platelet-derived growth factor and vascular endothelial growth factor, which are shown to increase BBB permeability and stimulate angiogenesis14,75,76,77. By introducing an initial culture of isolated capillary fragments and combining this with puromycin treatment (4 µg/mL) and use of PDS, we succeeded in greatly reducing the number of contaminating cells remaining after the purification, so that thereafter we could establish tight endothelial monolayers on permeable membrane inserts. In order to ensure the best attachment of endothelial cells on both culture dishes and permeable membrane insert surfaces, it has been observed that a coating mixture of collagen type IV (from human placenta) and fibronectin greatly increases the proliferation yields, and the combined mixture was therefore favored over the traditional method using only collagen type I78.
Differentiation of Cells and the Establishment of a High TEER In Vitro BBB Model
The pBECs in MC generally retain many BBB key features following isolation, so that co-culture with astrocytes is not essential for inducing functional tight junctions and achieving high TEER values16,57. Efforts to optimize the conditions for differentiation of the endothelial cells into BBB phenotype include use of serum-containing medium supplemented with 8-CPT-cAMP, hydrocortisone7 (increasing the intracellular cAMP level13) and RO 20-1724 (maintaining the intracellular cAMP level), which in accordance with previous findings74,79 together successfully improved the barrier tightness and increased TEER, and may also have helped to restore a more in vivo like gene expression profile80. However, the use of hydrocortisone for the tightening of the endothelial layer may modify the response of the endothelial cells to certain stimuli, and for the purpose of using the model for investigation of responses to chemo- and cytokines during inflammation, the use of hydrocortisone may need to be avoided.
From comparative studies with MC, MC with ACM and astrocyte co-cultures in both the participating laboratories and elsewhere, it has been shown that astrocytic contribution is capable of improving endothelial BBB features and increasing the barrier tightness21,40,42,49,79,81,82,83. In order to achieve such high expression of BBB phenotype in pBECs, we established a NCC with astrocytes and found that both porcine and rat primary astrocytes were beneficial, as also observed in other laboratories22. During the establishment of the astrocyte NCCs, experience has shown that the purity and age of the astrocyte cultures influence the resulting endothelial barrier tightness, with the optimum age of the astrocytes being 2-8 weeks, which correlates with an observed change in the astrocyte morphology over time. On the day before establishing the NCC, a medium change for the astrocytes is intended to remove harmful metabolites and allow enough time for the astrocytes to release stimulation and signaling factors influencing the barrier development. When co-culturing the endothelial cells and astrocytes in the permeable membrane insert system, it is important to pay special attention to the handling of the barrier model. During medium change, both aspiration and addition of the medium and the movements of the inserts must be done carefully in order to minimize disruption of the endothelial barrier.
Reproducibility and Reliability
A great challenge when using primary cells for establishing in vitro models is to achieve high reproducibility between cultures. Such standardization may be met by the choice of method, use of high quality tools and reagents, and experience in microdissection. The high reproducibility with low batch-to-batch variation for the presented method is therefore highly dependent on strict adherence to the described procedures.
To achieve a good reproducibility between batches and vials during TEER measurements, a tissue resistance measurement chamber or epithelial voltmeters with rigid miniature electrodes, rather than flexible chopstick electrodes can be used, reducing the variability of observed TEER values. In addition to achieving high TEER values (Figure 4), the reliability of the presented model is confirmed by the corresponding low small solute permeability (Figure 4), and by the immunocytochemical characterization of the pBECs (Figure 5).
Limitations of the Applied Method and Model
The use of transgenic and miniature pigs has increased during the last decades, but the amount of in vivo data is still limited compared to data available for rodent models, and therefore may pose a challenge for comparing the in vitro porcine data with in vivo results. However, as the biology of the pig reflects human biology more closely than many established laboratory animals, and transgenic pig models for studying neurological diseases such as Alzheimer's disease have now been established84, the availability of in vivo data is expected to become less problematic with time.
A limitation of the current permeable membrane insert system models of the BBB is the inability to mimic the blood flow in microvessels. In vivo, shear stress has been shown to affect many aspects of endothelial cell physiology such as division, differentiation, migration and apoptosis85,86, and to influence important BBB characteristics such as the expression of junctional proteins, and the induction and polarization of transporters61,85,87. To introduce such conditions, newly developed microfluidic systems can be considered88,89,90.
A useful method to correct for the effect of the unstirred water layer (aqueous boundary layer) from in vitro permeability data is to derive the predicted 'intrinsic permeability' in vivo, using the software based approach21. This software can also be used for detailed permeability data analysis21.
Future Applications and Directions for the Method
As the components of neurovascular unit have been shown to play important roles in inducing and maintaining BBB features, and no current in vitro model has yet been able to fully mimic the in vivo conditions, important constituents and interactions may still be missing. Current efforts in developing the presented model include establishing triple-culture models with both astrocytes and pericytes, and experiments combining cells of different species. Incorporation of pericytes has so far has not been observed to significantly increase the TEER levels of the barrier. However, syngeneic porcine models have been observed to be comparable to triple cultures using porcine brain endothelial cells, rat astrocytes, and rat pericytes with respect to barrier tightness and expression of hallmark proteins characteristic of the brain endothelium22. In order to develop a model based on human cells, future developments of in vitro BBB models for drug discovery and delivery may rely on the derivation of human pluripotent stem cells and adult stem and/or progenitor cells21.
The authors have nothing to disclose.
The authors would like to acknowledge Elisabeth Helena Bruun, Sarah Christine Christensen, and Niels M. Kristiansen for technical assistance, and the Lundbeck Foundation grant number R155-2013-14113.
Fibronectin | Sigma-Aldrich | F1141 | |
Collagen IV | Sigma-Aldrich | C5533 | |
Poly-L-lysine | Sigma-Aldrich | P1524 | |
DMEM/F-12 | Lonza | BE12-719F | |
DMEM/Low Glucose | Sigma-Aldrich | D6046 | |
Penicillin/Streptomycin | Gibco Invitrogen | 15140 | |
Plasma derived serum (PDS) | First Link UK Ltd. | 60-00-89 | |
Fetal bovine serum (FBS) | Gibco Invitrogen | 10-270-106 | |
Trypsin/EDTA | Gibco Invitrogen | 15090-046 | |
Heparin | Sigma-Aldrich | H3393 | |
Puromycin | Sigma-Aldrich | P8833 | |
Hydrocortisone | Sigma-Aldrich | H4001 | |
8-CPT-cAMP | Biolog | C010 | |
RO 20-1724 | Sigma-Aldrich | B8279 | |
Gentamicin Sulfate | Lonza | 17-518Z | |
DMSO | Sigma-Aldrich | 34896 | |
PBS | Sigma-Aldrich | D8537 | |
EtOH | VWR | 20,824,296 | Mix the 70 % solution from the 96 % EtOH |
DNAse 1 | Sigma-Aldrich | D4513 | |
Collagenase CLS2 | Sigma-Aldrich | C6885 | |
ddH2O | Made with Elga System | ||
T75 flasks | Thermo Scientific | 156499 | |
Costar Transwell inserts (Cell permeable membrane inserts) | Costar | CLS3401 | 12-well plate, 12 mm diameter, 0.4 μm polycarbonate membrane |
15 ml centrifuge tubes | Cellstar | 188271 | |
50 ml centrifuge tubes | Cellstar | 227261 | |
Petri dishes | Thermo Scientific | 150350 | |
Cryo vials | Thermo Scientific | 377224 | |
500 ml bottle | Thermo Scientific | 159910/159920 | |
Scalpels | Swann-Morten | REF0211 | Type 24 |
Tissue homogenizer | Sigma | D9188 | |
140 μm filters | MERCK | NY4H04700 | |
40 μm filters | Corning | 431750 | |
EndOhm chamber system | World Precision Instruments | ENDOHM-12 | EndOhm chamber for 12mm Culture Cups |
EVOM2 electrode system | World Precision Instruments | 300523+STX100C | TEER measurement system with rigid STX-100C electrode pair |
Long needle | Sigma | Attach to a syringe | |
Fine-tip curved forceps | KLS Martin | 12-409-12-07 | |
Broad tip forceps | VWR | 82027-390 | |
Filter holder | MERCK Milipore | Swinnex-47 | |
50 ml syringe | Braun | 4617509F | |
10 ml syringe | Terumo | SSt20ESI | |
Anti-Occludin antibody | Abcam | ab31721 | 1:100 |
Anti-p120 Catenin antibody | BD Transduction laboratories | 610133 | 1:200 |
Anti-ZO-1 antibody | Invitrogen | 61-7300 | 1:200 |
Anti-Claudin 5 antibody | Sigma-Aldrich | SAB4502981 | 1:100 |
Donkey anti rabbit IgG conjugated with Alexa Flour 568 | Thermo Scientific | A10042 | 1:500 |
Donkey anti mouse IgG conjugated with Alexa Flour 488 | Thermo Scientific | A21202 | 1:500 |
Sucrose | Perkin Elmer | NEC100X250UC | 0.15µl/ml final working conc |
Lucifer Yellow | Sigma | L0144 | 10 µg/ml final working conc |